Global Angong Niuhuang Pill Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Angong Niuhuang Pill Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
An effective first-aid medicine against fever or other more serious health problems. Except for treating high fever, the Niuhuang pill is also used for strokes, headaches, dizziness, epilepsy and nausea.
Angong Niuhuang Pill report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angong Niuhuang Pill market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Stroke and Coma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angong Niuhuang Pill industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angong Niuhuang Pill key manufacturers include Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Mapakleung Co., Ltd, Jiuzhitang Co., Ltd., Wai Yuen Tong Medicine Co.,Ltd., Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. and Shandong Hongjitang Co., Ltd., etc. Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited are top 3 players and held % sales share in total in 2022.
Angong Niuhuang Pill can be divided into Natural Ingredients and Synthetic Ingredients, etc. Natural Ingredients is the mainstream product in the market, accounting for % sales share globally in 2022.
Angong Niuhuang Pill is widely used in various fields, such as Stroke, Coma, Centric Fever and Viral Encephalitis, etc. Stroke provides greatest supports to the Angong Niuhuang Pill industry development. In 2022, global % sales of Angong Niuhuang Pill went into Stroke filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angong Niuhuang Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Beijing TRT Group
GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Mapakleung Co., Ltd
Jiuzhitang Co., Ltd.
Wai Yuen Tong Medicine Co.,Ltd.
Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
Shandong Hongjitang Co., Ltd.
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Segment by Type
Natural Ingredients
Synthetic Ingredients
Stroke
Coma
Centric Fever
Viral Encephalitis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Angong Niuhuang Pill market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angong Niuhuang Pill, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angong Niuhuang Pill industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Angong Niuhuang Pill in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angong Niuhuang Pill introduction, etc. Angong Niuhuang Pill Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Angong Niuhuang Pill market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Angong Niuhuang Pill report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angong Niuhuang Pill market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Stroke and Coma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angong Niuhuang Pill industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angong Niuhuang Pill key manufacturers include Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Mapakleung Co., Ltd, Jiuzhitang Co., Ltd., Wai Yuen Tong Medicine Co.,Ltd., Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. and Shandong Hongjitang Co., Ltd., etc. Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited are top 3 players and held % sales share in total in 2022.
Angong Niuhuang Pill can be divided into Natural Ingredients and Synthetic Ingredients, etc. Natural Ingredients is the mainstream product in the market, accounting for % sales share globally in 2022.
Angong Niuhuang Pill is widely used in various fields, such as Stroke, Coma, Centric Fever and Viral Encephalitis, etc. Stroke provides greatest supports to the Angong Niuhuang Pill industry development. In 2022, global % sales of Angong Niuhuang Pill went into Stroke filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angong Niuhuang Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Beijing TRT Group
GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Mapakleung Co., Ltd
Jiuzhitang Co., Ltd.
Wai Yuen Tong Medicine Co.,Ltd.
Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
Shandong Hongjitang Co., Ltd.
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Segment by Type
Natural Ingredients
Synthetic Ingredients
Segment by Application
Stroke
Coma
Centric Fever
Viral Encephalitis
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Angong Niuhuang Pill market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angong Niuhuang Pill, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angong Niuhuang Pill industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Angong Niuhuang Pill in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angong Niuhuang Pill introduction, etc. Angong Niuhuang Pill Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Angong Niuhuang Pill market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices